Immunotherapy before surgery shows promise for certain colorectal cancers

NCT ID NCT05197322

First seen Apr 24, 2026 · Last updated May 02, 2026 · Updated 1 time

Summary

This study tests whether giving the immunotherapy drug pembrolizumab before surgery can help people with a specific type of colorectal cancer (called MMR-deficient or MSI-high). The drug helps the immune system fight cancer cells. The goal is to see if this approach is safe, improves the chance of removing the entire tumor, and delays or prevents the cancer from coming back. About 88 participants will receive up to 9 weeks of pembrolizumab before their planned surgery and will be followed for at least 3 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE COLON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Addenbrookes Hospital

    RECRUITING

    Cambridge, CB2 0QQ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Beatson West of Scotland Cancer Centre

    RECRUITING

    Glasgow, G12 0YN, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Christie Hospital NHS Trust, Wilmslow Road,

    RECRUITING

    Manchester, M20 4BX, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Southampton General Hospital

    COMPLETED

    Southampton, SO16 6YD, United Kingdom

  • St James University Hospital (SJUH)

    COMPLETED

    Leeds, LS9 7TF, United Kingdom

  • University College Hospital

    RECRUITING

    London, NW1 2BU, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.